Invesco
ALXN

Invesco’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,052,026
Closed -$193M 4057
2021
Q2
$193M Sell
1,052,026
-87,037
-8% -$16M 0.05% 541
2021
Q1
$174M Sell
1,139,063
-9,251
-0.8% -$1.41M 0.05% 546
2020
Q4
$179M Buy
1,148,314
+96,795
+9% +$15.1M 0.05% 480
2020
Q3
$120M Buy
1,051,519
+67,198
+7% +$7.69M 0.04% 560
2020
Q2
$110M Sell
984,321
-235,015
-19% -$26.4M 0.04% 557
2020
Q1
$109M Sell
1,219,336
-348,357
-22% -$31.3M 0.05% 472
2019
Q4
$170M Sell
1,567,693
-1,873,516
-54% -$203M 0.05% 469
2019
Q3
$337M Buy
3,441,209
+158,519
+5% +$15.5M 0.09% 266
2019
Q2
$430M Sell
3,282,690
-433,462
-12% -$56.8M 0.11% 213
2019
Q1
$502M Buy
3,716,152
+42,353
+1% +$5.73M 0.17% 130
2018
Q4
$358M Sell
3,673,799
-393,420
-10% -$38.3M 0.14% 165
2018
Q3
$565M Sell
4,067,219
-229,092
-5% -$31.8M 0.18% 127
2018
Q2
$533M Buy
4,296,311
+408,700
+11% +$50.7M 0.18% 131
2018
Q1
$433M Sell
3,887,611
-234,823
-6% -$26.2M 0.16% 146
2017
Q4
$493M Sell
4,122,434
-595,361
-13% -$71.2M 0.18% 129
2017
Q3
$662M Buy
4,717,795
+313,971
+7% +$44M 0.24% 85
2017
Q2
$536M Buy
4,403,824
+708,900
+19% +$86.3M 0.17% 132
2017
Q1
$448M Sell
3,694,924
-4,140
-0.1% -$502K 0.15% 153
2016
Q4
$453M Buy
3,699,064
+609,546
+20% +$74.6M 0.15% 147
2016
Q3
$379M Buy
3,089,518
+682,824
+28% +$83.7M 0.13% 179
2016
Q2
$281M Sell
2,406,694
-421,342
-15% -$49.2M 0.1% 223
2016
Q1
$394M Sell
2,828,036
-366,210
-11% -$51M 0.16% 148
2015
Q4
$609M Sell
3,194,246
-34,485
-1% -$6.58M 0.24% 83
2015
Q3
$505M Buy
3,228,731
+270,160
+9% +$42.3M 0.21% 96
2015
Q2
$535M Buy
2,958,571
+306,791
+12% +$55.5M 0.21% 103
2015
Q1
$460M Sell
2,651,780
-481,450
-15% -$83.4M 0.18% 124
2014
Q4
$580M Sell
3,133,230
-215,615
-6% -$39.9M 0.22% 98
2014
Q3
$555M Sell
3,348,845
-421,756
-11% -$69.9M 0.22% 92
2014
Q2
$589M Sell
3,770,601
-382,880
-9% -$59.8M 0.23% 90
2014
Q1
$632M Buy
4,153,481
+612,007
+17% +$93.1M 0.26% 69
2013
Q4
$471M Buy
3,541,474
+442,215
+14% +$58.8M 0.19% 107
2013
Q3
$360M Buy
3,099,259
+789,973
+34% +$91.8M 0.16% 136
2013
Q2
$213M Buy
+2,309,286
New +$213M 0.1% 235